Medical Device | November 17, 2021
Cipla launches Spirofy for early diagnosis of COPD
It is India’s first pneumotach based portable wireless Spirometer for diagnosis of Chronic Obstructive Pulmonary Disorder (COPD)
It is India’s first pneumotach based portable wireless Spirometer for diagnosis of Chronic Obstructive Pulmonary Disorder (COPD)
Launching in 2022, its availability will be expanded to the global market
Two out of three people under the age of 40 are at risk of prediabetes
Forty-two per cent Indian patients with Coronary Artery Disease (CAD) or Peripheral Artery Disease (PAD) described “confusion about what I was supposed to do next” as an important barrier to early and accurate diagnosis
The company performed particularly well in operational eco-efficiency, environmental and social reporting
The European Commission (EC) granted marketing authorisation for Celltrion’s regdanvimab following a positive opinion by the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) last week
The interim data combines three mRNAs into one therapy injected directly into the tumour
The company expects to begin shipping this product before the end of its fiscal first quarter, ending December 31, 2021
Natco Pharma has reported consolidated financial results for the period ended September 30, 2021
The centre has an initial capacity of 500 FTEs
Subscribe To Our Newsletter & Stay Updated
